Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
12 hedge funds and large institutions have $595K invested in Guardion Health Sciences, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
71% more capital invested
Capital invested by funds: $348K → $595K (+$247K)
9% more funds holding
Funds holding: 11 → 12 (+1)
0.06% more ownership
Funds ownership: 5.09% → 5.15% (+0.06%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$8.65K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.48K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.03K |
| 3 |
S
SignatureFD
Atlanta,
Georgia
|
-$107 |
GHSI Hedge Fund Activity: Q1 2024 in Review
12 of the 6,960 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q1 2024, worth a combined $595K — up 71% from $348K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GHSI positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $8.65K. The largest seller was Renaissance Technologies, cutting an estimated $1.48K.
- 12 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q1 2024, up from 11 in Q4 2023.
- Funds reported $595K of Guardion Health Sciences, Inc. Common Stock stock for Q1 2024, up 71% quarter-over-quarter.
- 2 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q1 2024 was UBS Group, an estimated $8.65K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q1 2024 was Renaissance Technologies, an estimated $1.48K sold.
Based on aggregated 13F filings for Q1 2024.